"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"


Genpharm Services is a financially sound privately owned company based in the Dubai Biotechnology and Research Park (DuBiotech), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Genpharm's Corporate Video

See Genpharm’s Corporate Video presentation. Hear from the founders and employees about the mission of Genpharm. Listen to how employees are contributing to the community and empowering the Rare Disease Community in the MENA region.


"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

The Interview of Karim Smaira by Entrprenergy

Listen to the podcast and interview of Karim Smaira by Entrprenergy,The portal for Entrepreneurs in the Middle East: The Road to Entrepreneurship and the foundation of Genpharm. What it takes to be an entrepreneur? The importance of networking and a support environment, lessons learnt from previous failures, the need for a long-term vision and objectives. These are some of the points discussed in this candid discussion.

Gene Therapy: The Next Frontier in the Treatment of Genetic & Rare Disease.

Gene therapy is the use of genes as treatment for a genetic disease by directing the expression of a therapeutic protein or restoring the expression of a missing protein. It involves the transfer of a therapeutic or working gene copy into specific cells of an individual to repair a faulty gene copy or to introduce a new gene whose function is to cure or to favorably modify the clinical course of a condition.

ASPIRE Educational Series

Part of our commitment to patients and physicians across the MENA region, Genpharm is launching the first and only ASPIRE Educational Series focused on CNS and Neurological disorders, in collaboration with the online portal Kayf.TV. The campaign is based on a broad range of educational videos and interviews with some of the most prominent neurologists in the field of clinical practice and research.

White Paper

MENA Market: An Attractive Opportunity for Rare Disease and Healthcare Companies. Get your free copy by clicking on the Download button.

MENA Women's Health Congress

Genpharm is a proud sponsor of the MENA Women's Health Congress, to be held in Dubai, UAE during November 5th - 7th 2015. The MENA Women's Health Congress 2015 aims to discuss the latest medical achievements to improve women's health.

World Orphan Drug Congress - Europe 2015

Genpharm is a proud sponsor of the 6th Annual World Orphan Drug Congress, to be held in Geneva, Switzerland during November 12th - 13th 2015. WODC is the premier commercial event for the global rare disease industry. World Orphan Drug Congress Europe is packed with great content exploring clinical development, patient partnerships, regulatory approval, reimbursement, exploiting global trends, manufacturing, distribution, orphan drug business models and commercialization strategies.

GENPHARM Services - Your Gateway to the MENA Pharmaceutical Market

We are a specialty pharmaceutical marketing and consulting company, providing our strategic partners with fast and sustainable market access into the MENA (Middle East & North Africa) region, including business development, in-licensing and more. We operate through evidence-based medicine and the highest ethical standards. Our expertise is based on an in-depth knowledge of the pharmaceutical market and the local business culture. Furthermore, our vast experience and the trusted network of partners allow us to deliver market opportunities for specialty, rare disease, biotech and innovative healthcare organizations.

The MENA region has been experiencing fast economic and sustainable GDP growth. This positive outlook is driven by several factors providing pharmaceutical companies with untapped regional opportunities...
The healthcare sector in the MENA region has been experiencing sustainable double digit growth. Driven by unmet medical needs and increased medical public awareness, governments have been heavily investing in both infrastructure and access
We operate through a holistic market approach. We manage all relevant stakeholders for our partners, including Physicians, Patient groups, distributors and payers. Our expertise include KOL management, advocacy and CME programs..
Genpharm Services is managed by highly experienced Pharma executives. The operations are led by staff with a strong track record in senior leadership roles in multinational pharmaceutical organizations...